Press Releases
Events
News Archive
Virtual Press Room

 

 

 DOBI Medical International to Host Investor Conference Call

Return to Press Releases

Mahwah, NJ, January 31, 2006  – DOBI Medical International, Inc. (DBMI.OB) will hold an investor update conference call at 11:00am ET on Thursday, February 2, 2006.

Robert B. Machinist, Chairman of the Board of Directors and Phillip C. Thomas, President and CEO, will host the call which will include a brief presentation followed by questions and answers.

DOBI Medical invites interested participants to hear management’s discussion and join the call by dialing (877) 407-0778. International callers may access the call by dialing (201) 689-8565. A replay of the conference call will be available through February 9, 2006 by dialing (877) 660-6853 for domestic participants and (201) 612-7415 for international participants. When prompted, participants should enter pass code 286 and conference ID number 191178.

About DOBI Medical International, Inc.
DOBI Medical is a developmental stage, medical imaging company working to create a new means for the improved diagnosis of malignant breast disease through the identification of abnormal vascularization ("angiogenesis") associated with tumors. The Company’s first application of the technology is the ComfortScan┬« system, a gentle, noninvasive, and nonionizing, optical imaging system designed to assist physicians in the identification and management of breast cancer as an adjunct to screening mammography. The ComfortScan system is intended to achieve this by providing new, physiology-based imagery of abnormal vascularization in the breast that is not readily available today. The ComfortScan system has CE Mark and UL designations, and DOBI Medical is a certified ISO 9001:2000 and ISO 13485:2003 company. The ComfortScan system is not yet commercially available in the U.S. as it is limited by U.S. law to investigational use until approved by the FDA, which cannot be guaranteed. Sales of the ComfortScan system to international distributors are limited to sales for investigational use for installation at clinical trial sites. For more information on DOBI Medical International or the ComfortScan system, visit igaot.pt.

Return to Press Releases

For further information:
Please contact: Michael Jorgensen, Chief Financial Officer
201-760-6464
mike@igaot.pt

DOBI Medical International
1200 MacArthur Blvd.
Mahwah, New Jersey 07430
Voice: (201) 760 6464
Fax: (201) 760 8860
e-mail: information@igaot.pt